We are testing a new treatment called AD04 to see if it can slow the progression of early Alzheimer’s disease. The study will also evaluate the safety of AD04 and its effects on quality of life.
Health conditions and diseases that the clinical trial is designed to study and treat.
Early Alzheimer's disease is the initial stage of Alzheimer's, a progressive brain disorder that affects memory, thinking, and behavior. In this stage, individuals may experience mild memory loss and confusion, which can impact daily activities.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.